Mesa Laboratories, Inc.
MLAB
$105.48
-$1.87-1.74%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -4.14M | 3.63M | 2.48M | 4.74M | -7.11M |
| Total Depreciation and Amortization | 5.75M | 5.72M | 5.85M | 5.96M | 7.50M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.42M | 4.93M | 5.35M | -855.00K | 2.60M |
| Change in Net Operating Assets | 3.93M | 4.48M | -5.45M | -7.95M | 9.69M |
| Cash from Operations | 13.96M | 18.75M | 8.22M | 1.89M | 12.67M |
| Capital Expenditure | -417.00K | -732.00K | -1.09M | -1.01M | -757.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -250.00K |
| Cash from Investing | -417.00K | -732.00K | -1.09M | -1.01M | -1.01M |
| Total Debt Issued | 0.00 | 0.00 | 97.00M | 10.50M | 0.00 |
| Total Debt Repaid | -14.69M | -8.69M | -103.44M | -7.44M | -17.94M |
| Issuance of Common Stock | -- | -- | -- | -- | 2.64M |
| Repurchase of Common Stock | -1.06M | -- | -- | -- | -887.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -884.00K | -884.00K | -882.00K | -873.00K | -870.00K |
| Other Financing Activities | 873.00K | -214.00K | -564.00K | -10.62M | 858.00K |
| Cash from Financing | -15.76M | -9.79M | -7.88M | -8.43M | -16.19M |
| Foreign Exchange rate Adjustments | 167.00K | 316.00K | -104.00K | 1.50M | 900.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.05M | 8.55M | -857.00K | -6.04M | -3.64M |